Highlights
NASDAQ: GLPG       Galapagos NV
Last Price Today's Change   Day's Range   Trading Volume
227.69   +1.54 (0.68%)  227.25 - 229.86  142,900

Overview

 
Avg Volume (4 weeks):106,338
4 Weeks Range:204.70 - 229.86
4 Weeks Price Volatility (%):
91.38%
52 Weeks Range:94.75 - 229.86
52 Weeks Price Volatility (%):
98.39%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Galapagos is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company’s product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.

  Be the first to like this.
 


 

3414  4674  636  186 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 4.67+0.30 
 TTNP 0.334+0.084 
 SPY 331.95+1.03 
 SNCA 1.60+0.35 
 EEM 46.23+0.26 
 AVP 5.60-0.05 
 AMD 50.93+1.16 
 CHK 0.661-0.029 
 BAC 34.71-0.01 
 GE 11.81-0.03 
Partners & Brokers